Q2 2025 Holdings
Filed 2025-07-10 | 8 holdings | $91.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $69.0M | 1,047,557 | 75.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $19.9M | 457,059 | 21.7% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $1.7M | 816,375 | 1.9% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $454.0K | 667,742 | 0.5% |
| Carisma Therapeutics Inc(CARM) | COM | 14216R101 | $281.3K | 718,332 | 0.3% |
| Rallybio Corp | COM | 75120L100 | $255.1K | 754,678 | 0.3% |
| Sutro Biopharma Inc | COM | 869367102 | $124.9K | 175,000 | 0.1% |
| Rapt Therapeutics Inc(RAPTEUR) | COM NEW | 75382E109 | $99.5K | 12,437 | 0.1% |